Premaitha Share Discussion Threads

[michaelmouse] 15/2/2017 09:27

This morning they've announced a raising of £1.49m.

They have approx. £6.6m of debt with a 6% coupon.

That's £400,000 per annum in interest.

That leaves about £1m in cash.

Cash burn was running at £700,000 per month.

No wonder Adam Reynolds says, "We are delighted that a fund of Harwood's quality has identified the opportunity in Premaitha."

They'll need to call on them again soon.

[timojelly] 15/2/2017 09:07

Onwards and upwards, nice base formed, thanks for vote of confidence and the cash!

[hjb1] 15/2/2017 08:30

BLACK; Ramas.. totally agree! expecting more newsflow now.

[blackss] 15/2/2017 08:22

Agree with Twix, news release and price has been worked well to get this away at 8.75

[ramas] 15/2/2017 08:09

NIPT will likely partly rerate as investors come to conclude this is not a binary bet anymore and the downside has been far too pessimistic , imo of course

[twix386] 15/2/2017 07:54

yes, litigation resolved this Autumn for verdict if not settled earlier. Then we should re-rate. What a deramping picture you paint.

Hope your track record improves as this funding was meant to be at 5p and we all expected one at some point soonish. So its out of the way at 8.75p and along with revenue and writ costs covered.

What you should be saying is 'oh, that's better than expected and now it's done the next and final hurdle is the writ hearing in a little over 4 months time or settled beforehand.

[michaelmouse] 15/2/2017 07:46

Same attempt at Collagen. Except less successful. It goes on frequently.

twix386 - It mght have been 5p it weren't for "boiler room" tactics beforehand. ;)

Plenty more fundraisings to come. Believe me. I'd concentrate on pumping the share price if I were you or else the next fund raise will be 5p or below. Oh and then there's that litigation to sort out!

[pugg1ey] 15/2/2017 07:44

It may rise twix but I don't agree with your assessment. The newsflow was very vague and you could not have any idea how much the deals are worth to NIPT. How much were the deals they signed last year worth?
(I have no position here or intend to get one in the future, whatever the SP)

[twix386] 15/2/2017 07:39

what!!

So we get funds at 8.75p (not 5p michaelmouse) and from a respected player who see the potential and progress.

Who knows on this news where share price will go today, but it should continue its rise.

Funny Michaelmouse deramping on funding and price we could get it away at, and when totally wrong he senses a victory.lol

Sure, we needed to raise and the question was when, how much and at what price. Thankfull it was with newsflow at 8.75p.

I think this is quite okay.

[the shuffle man] 15/2/2017 07:39

Let's wait and see. They haven't raised the money from s bucket shop or death spiral finance. Don't think the new investor will flip them. I'm still holding and hope that they will come good if they can sort out illumina. Maybe the new investor has had some insight in this ?

[small crow] 15/2/2017 07:38

I see the general point but less than 7% dilution hardly significant if it allows the potential here.

[michaelmouse] 15/2/2017 07:35

It's disgusting isn't it? but it's happening increasingly frequently sadly and nobody is doing anything about it.

tsmith2 - "Imagine what price they would have got the fund raising away at had it not been for the pump.."

Some might suggest price manipulation. I couldn't possibly comment.

[runwaypaul] 15/2/2017 07:31

Dirty AIM.

[tsmith2] 15/2/2017 07:30

peeps been mugged. Imagine what price they would have got the fund raising away at had it not been for the pump..For all the contracts not once do we say any numbers and in meantime confetti time - tells you something imo

[pugg1ey] 15/2/2017 07:30

this does look like the behaviour of a share that TW usually slags off on his site. Release a few positive looking RNS's but with no financials attached. Tipped on a website, price jumps 25% then bang a fundraise.

[michaelmouse] 15/2/2017 07:22

LOL. Oh look they've raised another £1.5m with the issue of further equity. What a surprise. You know when the usual suspects are pumping up the price then a further fund raise is on the cards. There'll be a few more along the way you can be sure of that. Let's hope they don't lose the Illumina case shall we?

Posts 4347 and 4348. LOL. If only I had your analytical skills elrico.

Did somebody say price manipulation is rife? I couldn't possibly comment.

Worth a read of the weekends posts to get a feel for what goes on.

[timojelly] 15/2/2017 07:04

Well there you go...

[hjb1] 14/2/2017 23:09

taken from half year update, I can't see anyone else in Europe that fits the bill and as stated below "customers who have already tried offering NIPT through other providers" so maybe they have tried Natera but now want IONA as it is a better product!
They are not trialling IONA as they have signed a 4 year contract it seems.

"A combination of awareness of NIPT along with the reputation of the IONA® test for reliability and accuracy, has resulted in the IONA® test being adopted by both new laboratories and by customers who have already tried offering NIPT through alternative providers"

[hurricane.] 14/2/2017 23:03

Try again, Unilabs has licensed Natera's noninvasive prenatal testing technology

Maybe they are trialling both

[hjb1] 14/2/2017 22:18

jeeeez! if they can get into 50% of the labs then that would be mega! well 20% would be pretty good.

[hamidahamida] 14/2/2017 22:14

Happy days

[hjb1] 14/2/2017 22:07

looks like it's UNILABS?? who we partner, very exciting in with a big player if it is them, can't see anyone else in Europe that fits the bill.

at a glance;

Unilabs is a leading diagnostics company with one of the most extensive geographic coverages in Europe. We are present in: Denmark, Finland, France, Italy, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom. We are also operating laboratories in Peru and Dubai.

Unilabs employs more than 5,300 employees, from which 300 medical doctors.

Our wide range of services integrates laboratory medicine, medical imaging, histopathology, reproductive medicine, and drug development services. We serve: public and private healthcare providers, county councils, the general public, insurance companies, the pharmaceutical industry and CROs.

Number of laboratory medicine analyses (2015): 106M

Number of laboratories: +100

Number of radiology examinations (2015): 1.4 M

Radiology units: 45, of which

Mammography units: 19

Number of mammography screenings (per year): 354,000

Net sales 2015: €673M

Number of employees: >5,300

Number of medical doctors: 300

[elrico] 14/2/2017 21:14

Kaka - I don't disagree, but that's how the markets usually process bad news.

[kaka47] 14/2/2017 18:13

Concerns are overplayed This spike has strength we could get 15p